The Impact of Brief Messages on HSV-2 Screening Uptake Among Female Defendants in a Court Setting: A Randomized Controlled Trial Utilizing Prospect Theory-Reference-Cited by-同舟云学术

The Impact of Brief Messages on HSV-2 Screening Uptake Among Female Defendants in a Court Setting: A Randomized Controlled Trial Utilizing Prospect Theory

Published:2014-12-12 Issue:2 Volume:20 Page:230-236
ISSN:1081-0730
Container-title:Journal of Health Communication
language:en
Short-container-title:Journal of Health Communication

Author:

Roth Alexis M.,Van Der Pol Barbara,Fortenberry J. Dennis,Dodge Brian,Reece Michael,Certo David,Zimet Gregory D.

Publisher

Informa UK Limited

Subject

Library and Information Sciences,Public Health, Environmental and Occupational Health,Communication,Health (social science)

Link

http://www.tandfonline.com/doi/pdf/10.1080/10810730.2014.920062

Reference31 articles.

1. Using message framing to motivate HIV testing among low-income, ethnic minority women.

2. The effects of message framing on mammography utilization.

3. Incident and prevalent herpes simplex virus type 2 infection increases risk of HIV acquisition among women in Uganda and Zimbabwe

4. Centers for Disease Control and Prevention. (2009).2008 Sexually Transmitted Disease Surveillance Report. Retrieved from http://www.cdc.gov/std/stats08/default.htm

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Effects of Source Credibility and Message Framing on STI Screening Intentions: An Application of Prospect and Protection Motivation Theory;Journal of Health Communication;2019-11-14

2. A proposition-based theorizing approach to hotel cancellation practices research;International Journal of Contemporary Hospitality Management;2018-08-08

3. Addressing a statistical power-alpha level blind spot in political- and health-related media research: discontinuous criterion power analyses;Annals of the International Communication Association;2018-04-03

4. Type-specific detection of herpes simplex virus type 1 and type 2 using the cobas® HSV 1 and 2 test on the cobas® 4800 platform;Expert Review of Molecular Diagnostics;2016-10-08